These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 17970072

  • 1. Sodium butyrate regulates androgen receptor expression and cell cycle arrest in human prostate cancer cells.
    Kim J, Park H, Im JY, Choi WS, Kim HS.
    Anticancer Res; 2007; 27(5A):3285-92. PubMed ID: 17970072
    [Abstract] [Full Text] [Related]

  • 2. Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.
    Sadar MD, Gleave ME.
    Cancer Res; 2000 Oct 15; 60(20):5825-31. PubMed ID: 11059779
    [Abstract] [Full Text] [Related]

  • 3. Overexpressed androgen receptor linked to p21WAF1 silencing may be responsible for androgen independence and resistance to apoptosis of a prostate cancer cell line.
    Wang LG, Ossowski L, Ferrari AC.
    Cancer Res; 2001 Oct 15; 61(20):7544-51. PubMed ID: 11606392
    [Abstract] [Full Text] [Related]

  • 4. Zanthoxyli Fructus induces growth arrest and apoptosis of LNCaP human prostate cancer cells in vitro and in vivo in association with blockade of the AKT and AR signal pathways.
    Yang Y, Ikezoe T, Takeuchi T, Adachi Y, Ohtsuki Y, Koeffler HP, Taguchi H.
    Oncol Rep; 2006 Jun 15; 15(6):1581-90. PubMed ID: 16685399
    [Abstract] [Full Text] [Related]

  • 5. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
    Rocchi P, Tonelli R, Camerin C, Purgato S, Fronza R, Bianucci F, Guerra F, Pession A, Ferreri AM.
    Oncol Rep; 2005 Jun 15; 13(6):1139-44. PubMed ID: 15870934
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models.
    Gravina GL, Marampon F, Giusti I, Carosa E, Di Sante S, Ricevuto E, Dolo V, Tombolini V, Jannini EA, Festuccia C.
    Int J Oncol; 2012 Mar 15; 40(3):711-20. PubMed ID: 22134754
    [Abstract] [Full Text] [Related]

  • 7. Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells.
    Frønsdal K, Saatcioglu F.
    Prostate; 2005 Feb 15; 62(3):299-306. PubMed ID: 15389787
    [Abstract] [Full Text] [Related]

  • 8. Androgen sensitivity related proteins in hormone-sensitive and hormone-insensitive prostate cancer cell lines treated by androgen antagonist bicalutamide.
    Madarová J, Lukesová M, Hlobilková A, Riháková P, Murray PG, Student V, Vojtsek B, Kolár Z.
    Neoplasma; 2001 Feb 15; 48(5):419-24. PubMed ID: 11845989
    [Abstract] [Full Text] [Related]

  • 9. A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells.
    Ahn MY, Jung JH, Na YJ, Kim HS.
    Gynecol Oncol; 2008 Jan 15; 108(1):27-33. PubMed ID: 17920664
    [Abstract] [Full Text] [Related]

  • 10. Selenium modulation of cell proliferation and cell cycle biomarkers in human prostate carcinoma cell lines.
    Venkateswaran V, Klotz LH, Fleshner NE.
    Cancer Res; 2002 May 01; 62(9):2540-5. PubMed ID: 11980647
    [Abstract] [Full Text] [Related]

  • 11. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells.
    Fujimoto N, Miyamoto H, Mizokami A, Harada S, Nomura M, Ueta Y, Sasaguri T, Matsumoto T.
    Cancer Invest; 2007 Feb 01; 25(1):32-7. PubMed ID: 17364555
    [Abstract] [Full Text] [Related]

  • 12. Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification.
    Majid S, Kikuno N, Nelles J, Noonan E, Tanaka Y, Kawamoto K, Hirata H, Li LC, Zhao H, Okino ST, Place RF, Pookot D, Dahiya R.
    Cancer Res; 2008 Apr 15; 68(8):2736-44. PubMed ID: 18413741
    [Abstract] [Full Text] [Related]

  • 13. Growth of human prostate cancer cells is significantly suppressed in vitro with sodium butyrate through apoptosis.
    Qiu J, Gao Z, Shima H.
    Oncol Rep; 2012 Jan 15; 27(1):160-7. PubMed ID: 21947091
    [Abstract] [Full Text] [Related]

  • 14. Effects of apicidin, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
    Park H, Im JY, Kim J, Choi WS, Kim HS.
    Int J Mol Med; 2008 Mar 15; 21(3):325-33. PubMed ID: 18288380
    [Abstract] [Full Text] [Related]

  • 15. Change of the cell cycle after flutamide treatment in prostate cancer cells and its molecular mechanism.
    Wang Y, Shao C, Shi CH, Zhang L, Yue HH, Wang PF, Yang B, Zhang YT, Liu F, Qin WJ, Wang H, Shao GX.
    Asian J Androl; 2005 Dec 15; 7(4):375-80. PubMed ID: 16281084
    [Abstract] [Full Text] [Related]

  • 16. Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor.
    Trtková K, Pašková L, Matiješčuková N, Kolář Z.
    Cancer Biomark; 2010 Dec 15; 7(2):79-90. PubMed ID: 21178266
    [Abstract] [Full Text] [Related]

  • 17. Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.
    Liu CM, Lo YC, Tai MH, Wu BN, Wu WJ, Chou YH, Chai CY, Huang CH, Chen IJ.
    Prostate; 2009 May 01; 69(6):610-23. PubMed ID: 19143029
    [Abstract] [Full Text] [Related]

  • 18. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
    Gong J, Zhu J, Goodman OB, Pestell RG, Schlegel PN, Nanus DM, Shen R.
    Oncogene; 2006 Mar 30; 25(14):2011-21. PubMed ID: 16434977
    [Abstract] [Full Text] [Related]

  • 19. Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells.
    Davis T, Kennedy C, Chiew YE, Clarke CL, deFazio A.
    Clin Cancer Res; 2000 Nov 30; 6(11):4334-42. PubMed ID: 11106251
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells.
    He D, Falany CN.
    Prostate; 2007 Sep 01; 67(12):1318-29. PubMed ID: 17626250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.